Bellevue Group Ag Legend Biotech Corp Transaction History

Bellevue Group Ag

  • $4.31 Billion
  • Q1 2025

A detailed history of Bellevue Group Ag transactions in Legend Biotech Corp stock. As of the latest transaction made, Bellevue Group Ag holds 91,191 shares of LEGN stock, worth $3.24 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
91,191
Previous 167,341 45.51%
Holding current value
$3.24 Million
Previous $5.45 Million 43.18%
% of portfolio
0.07%
Previous 0.11%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$31.43 - $39.7 $2.39 Million - $3.02 Million
-76,150 Reduced 45.51%
91,191 $3.09 Million
Q4 2024

Feb 14, 2025
SELL
$32.49 - $50.28 $58,254 - $90,152
-1,793 Reduced 1.06%
167,341 $5.45 Million
Q3 2024

Nov 14, 2024
SELL
$43.55 - $59.88 $8.72 Million - $12 Million
-200,136 Reduced 54.2%
169,134 $8.24 Million
Q2 2024

Aug 14, 2024
BUY
$39.5 - $57.22 $3 Million - $4.35 Million
76,000 Added 25.91%
369,270 $16.4 Million
Q1 2024

May 15, 2024
BUY
$55.06 - $69.99 $5.04 Million - $6.41 Million
91,516 Added 45.36%
293,270 $16.4 Million
Q4 2023

Feb 14, 2024
SELL
$57.25 - $69.74 $4.37 Million - $5.33 Million
-76,400 Reduced 27.47%
201,754 $12.1 Million
Q3 2023

Nov 14, 2023
BUY
$63.16 - $76.5 $151,584 - $183,600
2,400 Added 0.87%
278,154 $18.7 Million
Q2 2023

Aug 14, 2023
SELL
$46.28 - $75.01 $10.7 Million - $17.4 Million
-231,500 Reduced 45.64%
275,754 $19 Million
Q1 2023

May 15, 2023
BUY
$43.42 - $57.37 $6.62 Million - $8.75 Million
152,465 Added 42.97%
507,254 $24.5 Million
Q4 2022

Feb 14, 2023
SELL
$38.8 - $55.46 $10.5 Million - $15 Million
-270,672 Reduced 43.28%
354,789 $17.7 Million
Q3 2022

Nov 14, 2022
SELL
$38.15 - $57.1 $189,910 - $284,243
-4,978 Reduced 0.79%
625,461 $25.5 Million
Q2 2022

Aug 11, 2022
SELL
$33.54 - $55.0 $993,790 - $1.63 Million
-29,630 Reduced 4.49%
630,439 $34.7 Million
Q1 2022

May 13, 2022
BUY
$31.02 - $48.18 $74,851 - $116,258
2,413 Added 0.37%
660,069 $24 Million
Q4 2021

Feb 10, 2022
BUY
$41.14 - $56.98 $15.3 Million - $21.1 Million
371,100 Added 129.5%
657,656 $30.7 Million
Q3 2021

Nov 12, 2021
SELL
$35.31 - $50.56 $3.66 Million - $5.24 Million
-103,607 Reduced 26.55%
286,556 $14.5 Million
Q2 2021

Aug 12, 2021
SELL
$25.8 - $41.09 $5.5 Million - $8.76 Million
-213,080 Reduced 35.32%
390,163 $16 Million
Q1 2021

May 12, 2021
BUY
$23.55 - $32.4 $4.4 Million - $6.06 Million
186,902 Added 44.89%
603,243 $17.5 Million
Q4 2020

Feb 16, 2021
BUY
$25.8 - $32.39 $10.7 Million - $13.5 Million
416,341 New
416,341 $11.7 Million
Q3 2020

Nov 16, 2020
SELL
$27.5 - $39.61 $3.69 Million - $5.32 Million
-134,261 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$36.1 - $42.56 $4.85 Million - $5.71 Million
134,261 New
134,261 $5.71 Million

Others Institutions Holding LEGN

# of Institutions
229
Shares Held
74.4M
Call Options Held
247K
Put Options Held
406K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.94B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email